Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the musculoskeletal space, located in “The Orthopedic Capital of the World” Warsaw, IN, is announcing the limited release of its newest product, the Axi+Line™ Proximal Bunion Correction System for the treatment of hallux valgus deformity, also known as a bunion. This announcement comes shortly after Nextremity Solutions announced the limited release of another new product, the PiroVue™ Gastrocnemius Recession System for the treatment of equinus deformities in patients.
According to a 2015 study in Foot & Ankle International® entitled, “A New Measure of Tibial Sesamoid Position in Hallux Valgus in Relation to the Coronal Rotation of the First Metatarsal in CT Scans”, patients with hallux valgus deformities (bunions) had a “more pronated first metatarsal than the control group”. The study showed that 87.3% of the patients sampled with hallux valgus deformity also had abnormal frontal plane rotation of the first ray.
Nextremity Solutions currently offers the Re+Line® Bunion Correction System, which specifically focuses on the treatment of hallux valgus deformities of lesser angles. However, the Axi+Line Proximal Bunion Correction System addresses treatment of deformities of larger angles and addresses correction in the frontal plane.
“The Axi+Line Proximal Bunion Correction System is a reproducible, guided, and fully disposable system for addressing hallux valgus deformities via a proximal metatarsal approach. This system takes advantage of the modified Mau osteotomy and addresses the concerns of rotational correction in the frontal plane while simultaneously reducing the hallux valgus angle. It provides surgeons with a great option between a distal approach and a Lapidus approach. We’re excited about the introduction of Axi+Line as well as our soon-to-launch Lapidus system,” commented Ryan D. Schlotterback, Chief Commercial Officer for Nextremity Solutions, Inc.
The patent-pending Axi+Line Proximal Bunion Correction System will utilize a limited launch with key surgeons prior to a full commercial launch in 2018.
For more information or to schedule a demonstration of the Axi+Line Proximal Bunion Correction System, please visit http://www.nextremity.com/axiline.
About Nextremity Solutions, Inc.
Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the musculoskeletal space, offering innovative solutions and Revenue Ready™ products for various musculoskeletal applications and for the benefit of our industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.
For further information, visit www.nextremitysolutions.com or call Dave Temple, Executive Director, i3 Direct at 574-635-3022.